Astrazeneca

Country

United Kingdom

Reference

GB-COH-02723534

AstraZeneca supplies medical equipment, pharmaceuticals and personal care products to NHS England, the Department of Health and Social Care and other public bodies across the United Kingdom, through 19 public contract awards. The company won 19 awards with 23 lots, for an approximate total of £89,921, over the period 2021 to 2025, with 2021 the year of most awards (6). NHS England is its main buyer, with 12 contracts, followed by The NHS Commissioning Board (operating under the name of NHS England) with 4 contracts, the Department of Health and Social Care with 2, and the Regional Business Services Organisation, Procurement and Logistics Service with 1. The most recent award is a £90,000 contract for «Generic, Branded Generic & Proprietary Medicinal Products - Group 16», awarded by the Regional Business Services Organisation in August 2025. Several awards are framework agreements for branded medicines, such as the «NHS Framework Agreement for Branded Medicines - National Tender» awarded by NHS England in June 2022, whose amount is the ceiling for all suppliers party to it rather than the sum paid to this company. A telling direct award is the «Contract for the supply of live attenuated intranasal influenza vaccine» from the Department of Health and Social Care in October 2021.

Interested in tenders like the ones Astrazeneca wins? Get the next public tenders published in the United Kingdom in the same sectors and from the same buyers, by email. Free, no card needed.